June 14, 2013
- What's Your "Why"?
- Colleague Close-up with April Seiler
- AHA 2014 Scientific Sessions: IMPROVE-IT Results Reported and What They Mean for the Future of ETC-1002
- 08-27-15 @EsperionInc is delighted to see another #LDL #cholesterol lowering therapy approved for patients in need of additional therapeutic options.
- 08-07-15 Ashley is former Global Regulatory Lead for cardio @ Amgen. Oversaw strategy & global filings for the evolocumab program - the 1st #PSCK9i.